Subscribe

AGF U.S. Market Neutral Anti-Beta Fund (BTAL)

USD11.86 +0.23 (+1.98%)
AMEX USD US Alternatives
NAV USD 11.51 +3.04% vs NAV as of 2026-06-06
AUM USD 275.53M
TER 1.43%
Yield (TTM) 3.02%
Distribution Distributing · Annual
52-week range 10.92 – 17.12
Holdings 121
Issuer AGF

About this ETF

The fund will invest primarily in long positions in low beta U.S. equities and short positions in high beta U.S. equities on a dollar neutral basis, within sectors. It will construct a dollar neutral portfolio of long and short positions of U.S. equities by investing primarily in the constituent securities of the Dow Jones U.S. Thematic Market Neutral Low Beta Index in approximately the same weight as they appear in the index. The universe for the index is comprised of the top 1,000 eligible securities by market capitalization, including REITs.

ISIN US00110G4082
Issuer AGF
Domicile US
Inception 2011-09-13
Asset class Alternatives

Price

Top 10 holdings

USD= USD= 61.72%
BTALU21L BTALU21L 7.58%
Acceleron Pharma Inc. XLRN 0.27%
FTI Consulting, Inc. FCN 0.27%
MarketAxess Holdings Inc. MKTX 0.27%
Valvoline Inc. VVV 0.27%
Flowers Foods, Inc. FLO 0.27%
VeriSign, Inc. VRSN 0.27%
Brown & Brown, Inc. BRO 0.27%
Quest Diagnostics Incorporated DGX 0.27%
See full holdings →